Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No significant changes detected on the study details page; the core information and layout remain as previously shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:05:49.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-05T17:39:42.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. No substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T11:17:16.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; a Back to Top link was removed (minor UI change).
    Difference
    0.2%
    Check dated 2025-09-14T00:52:36.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-06T21:25:26.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as a list of relevant publications from PubMed related to bladder cancer and associated genetic topics. Additionally, several outdated location entries and terms have been removed.
    Difference
    17%
    Check dated 2025-08-30T15:53:12.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.